Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 HKD | 0.00% |
|
+8.22% | -14.13% |
06-26 | Simcere Zaiming and Mabpharm Limited Announce Approval of Cetuximab Beta in China by the NMPA | CI |
06-25 | Simcere-Mabpharm Cancer Drug Gets Marketing Approval in China | MT |
1st Jan change | Capi. | |
---|---|---|
-14.13% | 209M | |
+15.82% | 122B | |
+20.35% | 114B | |
+18.20% | 25.71B | |
-25.31% | 19.02B | |
-21.16% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- 2181 Stock
- News Mabpharm Limited
- China Gives New Drug Application Approval to Mabpharm's Anti-Asthma Therapy